SBC Medical Group Holdings Reports Second Quarter 2026 Financial Results
SBC Medical reported Q2 2026 revenue of $49 million, up 13% year-over-year, while net income attributable to SBC Medical surged 335% to $11 million. Adjusted EBITDA increased 32% to $20 million with a 41% margin, driven by AI-enabled service enhancements, successful fee increases, and the expansion of the points business.
Key figures
- Eps
- 0.1
- Revenue
- 49000000
- Revenue Yoy
- 13%
- Locations
- 287
- Ltm visits
- 6.9 million
- Net income
- 11000000
- Net income yoy
- 335%
- Adjusted ebitda
- 20000000
- Net income margin
- 22%
- Adjusted ebitda yoy
- 32%
- Cash and equivalents
- 184311213
- Adjusted ebitda margin
- 41%
- Average spend per visit
- 287
AI analysis
Red flags2 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.